Roflumilast shows efficacy in 95% of plaque psoriasis patients

(1:3)

Roflumilast – A Potential New First Line Systemic Drug for Psoriasis | Claus Zachariae, MD | Denmark

(7:24)

IDEF Educational Series Beyond the Surface Exploring Topical Roflumilast

(1:54:55)

Raj Chovatiya, MD - What is the mechanism of action of topical roflumilast?

(41)

Andrew Alexis, MD, MPH - How is roflumilast different than other PDE4 inhibitors?

(57)

Dr. Benjamin Ungar Topical Roflumilast for the Treatment of Psoriasis

(9:29)

What Do the New Roflumilast Foam Data Mean for Psoriasis Patients?

(2:44)

IDEF Educational Series Treatment Innovation Discover ZORYVE roflumilast 0 15% for a new indicatio

(1:34)

Andrew Alexis, MD, MPH - Does roflumilast have data to support safety and efficacy in long-term use?

(46)

Roflumilast (Daliresp) Pharmacology

(12:5)

Raj Chovatiya, MD - Can topical roflumilast be used for younger patients?

(30)

Management of COPD: Update

(37:41)

Roflumilast: A Non-Steroidal Option for Atopic Dermatitis #Dermatology #AtopicDermatitis #SkinCare

(54)

Andrew Alexis, MD, MPH - Can you talk about the roflumilast indication for patients 12 and older?

(1:3)

Mark Lebwohl, MD - What are your thoughts on the formulation of topical roflumilast for patients?

(29)

Raj Chovatiya, MD, PhD: Discussing the FDA Approval of Roflumilast for Atopic Dermatitis

(3:21)

Mark Lebwohl, MD - What were the efficacy outcomes for roflumilast in Phase 3 clinical trials?

(34)

COPD: The GOLD, the Bad and the Ugly

(56:37)

Mark Lebwohl, MD - How quickly do patients see results with topical roflumilast?

(22)

Roflumilast tablets how to use: Uses, Dosage, Side Effects, Contraindications

(4:18)